The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation
Clinical trial NCT05220410 · COMPLETED
Trial details
- NCT number
- NCT05220410
- Sponsor
- Sheppard Pratt Health System
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-28
- Primary completion
- 2025-05-12
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.